|
MSMRD
|
Myeloma Stratification and Risk-Adapted Therapy with Reflex to Measurable/Minimal Residual Disease, Bone Marrow Mayo Clinic Laboratories in Rochester
|
|
MFCDF
|
Myeloma, High Risk with Reflex Probes, Diagnostic FISH Evaluation, Fixed Cell Pellet Mayo Clinic Laboratories in Rochester
|
|
MAS1
|
Myelopathy, Autoimmune/Paraneoplastic Evaluation, Serum Mayo Clinic Laboratories in Rochester
|
|
MAC1
|
Myelopathy, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid Mayo Clinic Laboratories in Rochester
|
|
MYPO
|
Myeloperoxidase (MPO) Immunostain, Technical Component Only Mayo Clinic Laboratories in Rochester
|
|
MPNCM
|
Myeloproliferative Neoplasm, CALR with Reflex to MPL, Varies Mayo Clinic Laboratories in Rochester
|
|
GNMY9
|
MYH9-Related Disorders, MYH9 Gene, Next-Generation Sequencing, Varies Mayo Clinic Laboratories in Rochester
|
|
MEF2B
|
Myocyte Enhancer Factor 2 (MEF2B) Immunostain, Technical Component Only Mayo Clinic Laboratories in Rochester
|
|
MYODT
|
MYOD1 Mutation Analysis, Next-Generation Sequencing, Tumor Mayo Clinic Laboratories in Rochester
|
|
MYOD1
|
Myogenic Differentiation Antigen 1 (MYOD1) Immunostain, Technical Component Only Mayo Clinic Laboratories in Rochester
|
|
MYOGE
|
Myogenin Immunostain, Technical Component Only Mayo Clinic Laboratories in Rochester
|
|
MYOGL
|
Myoglobin Immunostain, Technical Component Only Mayo Clinic Laboratories in Rochester
|
|
FMMPP
|
MyoMarker 3 Plus Profile Esoterix Endocrinology
|
|
FMYO3
|
MyoMarker 3 Profile Esoterix Endocrinology
|
|
MSAES
|
Myositis Specific Antibody Evaluation, Serum Mayo Clinic Laboratories in Rochester
|
Home
Help